UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000027138 |
|---|---|
| Receipt number | R000031092 |
| Scientific Title | Study on the effect of blood purification therapy on the immune system |
| Date of disclosure of the study information | 2017/05/01 |
| Last modified on | 2019/04/29 14:24:31 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Study on the effect of blood purification therapy on the immune system
Acronym
Study on the effect of blood purification therapy on the immune system
Scientific Title
Study on the effect of blood purification therapy on the immune system
Scientific Title:Acronym
Study on the effect of blood purification therapy on the immune system
Region
| Japan |
Condition
Condition
All diseases requiring blood purification therapy
Classification by specialty
| Nephrology | Neurology | Clinical immunology |
| Intensive care medicine | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The purpose of this study is to investigate the effects on autoimmune diseases, renal failure, septicemia, etc. on the immune system brought about by blood purification therapy and to use it for the treatment and selection of the target disease is there.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Number og Myeroid-derived suppressor cells
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 16 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Cases in which various blood purification therapy is performed in our artificial kidney section and intensive care section.
Key exclusion criteria
Cases in which consent was not obtained.
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Shigeto Oda |
Organization
Chiba University Graduate school of medicine and Chiba University Hospital
Division name
Department of Emergency and Critical Care Medicine an department of Artificial Kidney
Zip code
Address
1-8-1Inohana Chuoku Chiba City and Chiba,Japan
TEL
043-222-7171
nanayayacar@yahoo.co.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Hanae Wakabayashi |
Organization
Chiba University Graduate school of medicine and Chiba University Hospital
Division name
Department of Emergency and Critical Care Medicine an department of Artificial Kidney
Zip code
Address
1-8-1Inohana Chuoku Chiba City and Chiba,Japan
TEL
043-222-7171
Homepage URL
nanayayacar@yahoo.co.jp
Sponsor or person
Institute
Chiba-University Hospital
Institute
Department
Personal name
Funding Source
Organization
Scholarship donation
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 05 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2016 | Year | 09 | Month | 01 | Day |
Date of IRB
| 2016 | Year | 09 | Month | 01 | Day |
Anticipated trial start date
| 2016 | Year | 12 | Month | 08 | Day |
Last follow-up date
| 2019 | Year | 03 | Month | 30 | Day |
Date of closure to data entry
| 2019 | Year | 03 | Month | 30 | Day |
Date trial data considered complete
| 2019 | Year | 03 | Month | 30 | Day |
Date analysis concluded
Other
Other related information
Blood tests before and after treatment, blood tests after remission are performed and data analysis is in progress.
Management information
Registered date
| 2017 | Year | 04 | Month | 26 | Day |
Last modified on
| 2019 | Year | 04 | Month | 29 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031092
| Research Plan | |
|---|---|
| Registered date | File name |
| Research case data specifications | |
|---|---|
| Registered date | File name |
| Research case data | |
|---|---|
| Registered date | File name |
